ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Federal Court Rules In Favor Of Boston Scientific In J&J Patent Case

DOW JONES NEWSWIRES A federal court ruled a stent system made by Boston Scientific Corp. (BSX) doesn't infringe on Johnson & Johnson (JNJ) patents, a judgment that helps the medical-device maker notch a win in a patent war with the health-care products giant. Johnson & Johnson had alleged in a 2008 suit that Boston Scientific's Promus everolimus-eluting coronary stent system infringed on two of its patents. Boston Scientific on Monday touted a decision from a federal court in New Jersey, saying the court had found the patents to be invalid. "Boston Scientific will continue to vigorously defend against any claims of infringement," said Tim Pratt, general counsel for the company. A spokeswoman for Johnson & Johnson couldn't immediately be reached for comment. The two companies have been locked in a long-running battle over intellectual property for heart stents, with both scoring some victories along the way. Johnson & Johnson shares were recently down slightly to $65.25 premarket, while Boston Scientific were up 1.2% to $6.05. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
12/09/201617:22:00Nevro Announces Filing of Lawsuit by Boston Scientific
12/05/201616:08:26Statement of Changes in Beneficial Ownership (4)
12/05/201616:08:26Statement of Changes in Beneficial Ownership (4)
12/02/201607:00:00Boston Scientific Announces Agreement to Acquire Neovasc Advanced...
11/28/201618:25:00Nevro Files Lawsuit for Patent Infringement Against Boston Scientific...
11/23/201608:30:00Boston Scientific To Participate In Citi 2016 Global Healthcare...
11/22/201616:17:14Current Report Filing (8-k)
11/22/201608:36:00Boston Scientific Closes EndoChoice Acquisition
11/21/201607:00:00Boston Scientific Receives 2016 Shingo Prize for Operational...
11/16/201616:30:00Boston Scientific To Participate In Piper Jaffray 2016 Healthcare...
11/16/201613:34:00Boston Scientific Announces Positive Results Of HeartLogic™ H...
11/15/201606:30:00Boston Scientific Acquires Resectr™ Tissue Resection Device f...
11/04/201606:30:00Boston Scientific Announces Extension of the Cash Tender Offer...
11/03/201616:56:21Statement of Changes in Beneficial Ownership (4)
11/03/201616:51:34Statement of Changes in Beneficial Ownership (4)
11/03/201616:14:20Quarterly Report (10-q)
11/03/201606:30:00Boston Scientific Announces Acquisition Of The LumenR™ Tissue R...
11/02/201609:43:00Boston Scientific Announces Initial U.S. Commercial Performance...
11/02/201608:45:00The Shift of Medical Devices to a Home Setting
11/01/201616:11:05Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US